EPCAM and breast carcinoma: The data presented here, also demonstrated detection of EpCAM-CD81-containing EVs in small volumes of other biological fluids such as ascites from ovarian cancer patients, in general, in higher concentration than in plasma samples, in line with previous observations in breast cancer [39].